Corrigendum to "Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of <i>Coptis chinensis</i> Franchin Polycystic Ovary Syndrome".

Ma, Jian Xiong; Ye, Miaoyong; Ma, Ke; Zhou, Kang; Zhang, Yingying; Wang, Xiting; Tong, Hongxuan

Corrigendum to "Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of Coptis chinensis Franchin Polycystic Ovary Syndrome".

Ma, Jian Xiong; Ye, Miaoyong; Ma, Ke; Zhou, Kang; Zhang, Yingying; Wang, Xiting; Tong, Hongxuan.

Afiliación

Ma JX; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Ye M; Department of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100007, China.
Ma K; Department of Urology, The Affiliated Wenling Hospital of Wenzhou Medical University, Wenling, Zhejiang 317500, China.
Zhou K; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Zhang Y; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Wang X; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Tong H; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.

Evid Based Complement Alternat Med ; 2021: 9798627, 2021.

Article en En | MEDLINE | ID: mdl-34876917

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Evid Based Complement Alternat Med Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google